BDSI - BioDelivery Sciences International, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Valuation Measures
| Market Cap (intraday) 5 | 522.81M |
| Enterprise Value 3 | 520.52M |
| Trailing P/E | N/A |
| Forward P/E 1 | 26.55 |
| PEG Ratio (5 yr expected) 1 | -1.05 |
| Price/Sales (ttm) | 6.40 |
| Price/Book (mrq) | 7.90 |
| Enterprise Value/Revenue 3 | 6.38 |
| Enterprise Value/EBITDA 6 | -1,012.69 |
Trading Information
Stock Price History
| Beta (3Y Monthly) | 0.40 |
| 52-Week Change 3 | 58.63% |
| S&P500 52-Week Change 3 | 13.46% |
| 52 Week High 3 | 6.12 |
| 52 Week Low 3 | 2.80 |
| 50-Day Moving Average 3 | 5.13 |
| 200-Day Moving Average 3 | 4.57 |
Share Statistics
| Avg Vol (3 month) 3 | 695.49k |
| Avg Vol (10 day) 3 | 748.52k |
| Shares Outstanding 5 | 89.52M |
| Float | 69.38M |
| % Held by Insiders 1 | 6.00% |
| % Held by Institutions 1 | 58.77% |
| Shares Short (Oct 15, 2019) 4 | 4.2M |
| Short Ratio (Oct 15, 2019) 4 | 6.46 |
| Short % of Float (Oct 15, 2019) 4 | 5.16% |
| Short % of Shares Outstanding (Oct 15, 2019) 4 | 4.70% |
| Shares Short (prior month Sep 13, 2019) 4 | 3.99M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor (new per old) 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2018 |
| Most Recent Quarter (mrq) | Jun 30, 2019 |
Profitability
| Profit Margin | -34.73% |
| Operating Margin (ttm) | -8.25% |
Management Effectiveness
| Return on Assets (ttm) | -2.95% |
| Return on Equity (ttm) | -53.05% |
Income Statement
| Revenue (ttm) | 81.63M |
| Revenue Per Share (ttm) | 1.12 |
| Quarterly Revenue Growth (yoy) | 143.80% |
| Gross Profit (ttm) | 34.95M |
| EBITDA | -514k |
| Net Income Avi to Common (ttm) | -40.85M |
| Diluted EPS (ttm) | -0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 57.22M |
| Total Cash Per Share (mrq) | 0.64 |
| Total Debt (mrq) | 59.4M |
| Total Debt/Equity (mrq) | 89.79 |
| Current Ratio (mrq) | 2.34 |
| Book Value Per Share (mrq) | 0.74 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16.74M |
| Levered Free Cash Flow (ttm) | 3.64M |